ArticleFrontiers in public health2023

Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant

Wenqiang Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.